INTRODUCTION
Intestinal epithelial cells are part of the first line of defense against enterovirulent microbial pathogens [1] . The normal innate immune response to infection by enteropathogenic bacteria leads to chemokine-induced polymorphonuclear neutrophil (PMN) transmigration across the mucosal epithelium, normally leading to bacterial clearance and resolution of the infection [2] . A variety of bacterial factors, including fimbriae [3, 4] and flagellae [5] [6] [7] , can promote IL-8-dependent PMN transmigration across cultured epithelial cell monolayers through MAPK pathway activation [5] [6] [7] [8] .
Diffusely adherent Escherichia coli expressing Afa/Dr fimbriae (Afa/Dr DAEC) [9] belong to Group 6 of pathogenic E. coli [10] and can promote PMN transepithelial migration [3] . In vitro, the Afa/Dr DAEC strains C1845 (bearing F1845 fimbriae) and IH11128 (bearing Dr fimbriae) induce IL-8 synthesis by intestinal T84 cell monolayers via activation of MAPKs, including ERK, p38, and Src. This IL-8 secretion promotes transepithelial migration of PMN in vitro, which in turn, induces epithelial synthesis of TNF-␣ and IL-1␤, up-regulation of apical and basolateral decay-accelerating factor (DAF), and increased adhesion of Afa/Dr DAEC [3, 11] . These pathogenic E. coli can cause childhood diarrhea [12, 13] and are responsible for one-third of recurrent urinary tract infections (UTIs) in adults [14] . Afa/Dr DAEC express fimbriae encoded by a family of afa/dra/daa-related operons [9, 15] ; these fimbriae allow the bacteria to bind to epithelial cell membrane-associated receptors, including DAF and some carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) [9] .
Interactions between apical, enterovirulent E. coli colonizing the intestinal brush border and PMN are poorly documented. Brest et al. [16] found that Afa/Dr DAEC accelerated apoptosis of PMN isolated from human blood and led to decreased phagocytosis by transmigrated and nontransmigrated PMN, which are the first line of innate immune defenses, ingesting and killing invading microbes through several coordinated phenomena. The latter include release of preformed antimicrobial molecules stored in granules, generation of reactive oxygen species (ROS) by the NADPH oxidase system [17] , complex ion disequilibrium and charge compensation across the vacuolar wall [18] , formation of extracellular neutrophil traps [19] , and release of numerous cytokines facilitating bidirectional and multicompartmental interactions with immune cells and tissues [20] . In subjects with inflammatory bowel disease (IBD), this response can be excessive and deleterious [21] .
Here, we analyzed E. coli-induced PMN responses by using the human PLB-985 cell line differentiated into mature neutrophils and a set of E. coli strains. We found that these bacteria can interact directly with PLB-985 cells, leading to coordinated cell activation and mediator release, including a strong oxidative burst and rapid release of preformed myeloperoxidase (MPO) and IL-8, followed by late synthesis of IL-1␤, TNF-␣, and IL-8. Using wild-type (WT) enterovirulent, control, and recombinant E. coli strains, we showed that late IL-8 hyperproduction was triggered by type 1 pili but not by Dr or F1845 fimbriae, via MAPK (p38, ERK) and Src and NF-B activation.
MATERIALS AND METHODS

PLB-985 culture and differentiation
The human myeloid leukemia cell line PLB-985 [22] was a generous gift from Marie-Anne Gougerot-Pocidalo and Eric Pedruzzi (IB2M Inserm, CHU Bichat, Paris, France). The cells were cultured in RPMI-1640/glutamine medium (BioWhittaker, Walkerville, MD, USA), supplemented with 10% FCS (Cambrex BioSciences, Verviers, Belgium), 50 units/ml penicillin, and 50 g/ml streptomycin (Cambrex BioSciences) at 37°C in humidified air containing 5% CO 2 . Every 2 days, the cells were counted and incubated in fresh medium to maintain a cell density of 2 ϫ 10 5 -10 6 /ml. For granulocytic differentiation, exponentially growing cells at a starting density of 2 ϫ 10 5 /ml were cultured in RPMI-1640 medium, supplemented with 0.5% N,N-dimethyl formamide (DMF; Carlo Erba, Rodano, Italy), 1% Nutridoma-SP (Boehringer-Mannheim, Basel, Switzerland), and 0.5% FCS as described in ref. [23] . The medium was changed once on Day 3 during the 6-day differentiation period.
On Day 6, granulocytic differentiation was checked by morphological analysis of cytocentrifuged cells stained with May-Grü nwald-Giemsa on CD11b expression at the cell surface and on superoxide anion (O 2 -. ) production as described below.
Isolation of human blood PMN
Blood samples were obtained from informed, healthy volunteers. As described previously [24] , leukocytes were isolated by sedimentation on a separating medium containing 9% Dextran T500 (Pharmacia, Uppsala, Sweden) and 38% Radioselectan (Schering, Lys-lez-Lannoy, France). After red-cell sedimentation, the leukocyte-rich suspension was centrifuged on a Ficoll density gradient (Eurobio, Les Ulis, France). Contaminating erythrocytes were then removed by hypotonic lysis, and leukocytes were resuspended in HBSS (Ca   2ϩ   Mg 2ϩ , Life Technologies, San Diego, CA, USA) or PBS (Biomerieux, Marcy l'Etoile, France), depending on the experiment.
Bacteria and growth conditions
We used two WT Afa/Dr DAEC strains (IH11128 and C1845) [25, 26] and two recombinant strains (AAEC185pDr expressing Dr fimbriae and AAEC185pF1845 expressing F1845 fimbiae; see Table 1 ) [27, 28] . The laboratory strain AAEC185 lacking type 1 pili was used as a nonvirulent control [29] . Recombinant strain AAEC185pSH2 and mutant strain AAEC185pUT2002 [30] were generous gifts from Scott J. Hultgren (Washington University School of Medicine, St. Louis, MO, USA). The WT strain LF82 [31] and the recombinant strain AAEC185pAdLF82 [32] were a generous gift from Arlette Darfeuille-Michaud (USC INRA 2018, Université d'Auvergne, Clermont-Ferrand, France).
Stock cultures were maintained in 10% glycerol at -80°C. Before experiments, the bacteria were transferred onto fresh Luria-Bertani (LB) agar (Difco, Invitrogen, Cergy-Pontoise, France) and incubated at 37°C for 24 h. For each experiment, bacteria were subcultured in LB broth (medium) at 37°C for 18 h with appropriate antibiotics. On the day of the experiment, the bacteria were washed twice with sterile PBS, counted in a Salumbini chamber, and adjusted to 5 ϫ 10 9 CFU/ml HBSS for oxidative burst quantification. For cytokine analysis, bacteria were suspended in RPMI medium containing 10% FCS and killed by incubation with 200 g/ml gentamycin (Invitrogen) for 1 h.
LPS extraction
LPS was extracted from strains WT IH11128 (LPS-IH11128), WT C1845 (LPS-C1845), and AAEC185 (LPS-AAEC185) by using the hot phenol-water protocol as recommended by the manufacturer (LPS extraction kit, Intron Biotechnology, Korea). Briefly, strains were subcultured in LB medium for 18 h at 37°C and washed twice in PBS. Bacterial cells were lysed for 1 h at 60°C in a lysis buffer containing 0.42 mg/ml proteinase K. To separate LPS from other cell components, preparations were incubated for 10 min at -20°C in purification buffer. The LPS pellet was then washed with 70% ethanol to remove salt impurities. Endotoxin was quantified with the Limulus amebocyte lysate (LAL) chromogenic assay, as recommended by the manufacturer (LAL QCL-1000, Cambrex BioSciences).
Immunofluorescence
Differentiated PLB-985 cells plated on glass coverslips (5ϫ10 6 cells/ml) in 24-well tissue-culture plates were fixed in 3% paraformaldehyde-PBS for 15 min at room temperature. After washing three times with PBS, cells were treated with 50 mM NH 4 Cl for 10 min to neutralize aldehyde functions, followed by blocking with PBS containing 0.2% gelatin. Cells monolayers were AAEC185 strain expressing the type 1 pili variant of WT strain LF82 [32] incubated with mouse mAb 8D11, GM8G5, and 9A6 (Genovac, Freiburg, Germany), specific for DAF, CEACAM1, and CEACAM6, respectively, for 1 h at room temperature. 
Microscopic evaluation of bacteria adhesion to PLB-985-differentiated cells
Bacteria (AAEC185 and the recombinants AAEC185pDr and AAEC185pF1845) were adjusted at the final concentration of 5 ϫ 10 8 /ml in a buffer containing 50 mM sodium carbonate, 100 mM NaCl, and 100 g/mL FITC (Sigma-Aldrich Chimie SARL, L'Isle d'Abeau Chesnes, France) for 30 min at 37°C, while protected from light. The labeled bacteria were then washed three times, adjusted in HBSS at the concentration of 2 ϫ 10 8 -labeled bacteria/ml, and used immediately.
Differentiated PLB-985 cells were washed in HBSS and adjusted at 2 ϫ 10 6 cells/ml HBSS. This suspension (500 l) was put on glass coverslips in 24-well tissue-culture plates and incubated for 1 h at 37°C to ensure PLB-985 adherence. The medium was then removed, and 500 l freshly prepared FITC-labeled bacteria were added to the adherent cells. Plates were centrifuged slightly at 140 g for 5 min to synchronize infections and incubated at 37°C in a humidified atmosphere containing 7% CO 2 during 1 h. Glass coverslips were then washed three times with PBS to remove nonadherent bacteria, fixed with 3% paraformaldhyde, and washed again twice in PBS. DNA-binding Hoechst (Sigma-Aldrich Chimie SARL) was then added (2.5 g/ml) for 30 min. After washings, the coverslips were mounted in florescent mounting medium (DakoCytomation) and examined by conventional epifluorescence microscopy using a Leitz Aristoplan microscope (Leica). The number of bacteria per cell was determined for each bacteria strain.
Degranulation experiment
Cells (5ϫ10 6 /ml) in HBSS were incubated with the bacterial strains (5ϫ10 8 CFU/ml) or LPS (1 g/ml) at 37°C for 20 min in a water bath with gentle agitation. As a positive control to ensure total degranulation, cells were kept at 37°C for 5 min, incubated with 5 g/ml cytochalasin B (Sigma-Aldrich Chimie SARL) for 5 min, and then incubated with 10 Ϫ6 M fMLP (Sigma-Aldrich Chimie SARL) for 10 min as described previously [33] . Unstimulated control cells were kept at 37°C for 20 min in HBSS alone or maintained at 4°C. After centrifugation, all of the cell-free supernatants were stored at -80°C until IL-8 and MPO assays.
O 2
-. production O 2 -. production was measured with the superoxide dismutase-inhibitable reduction of the ferricytochrome C method, as described previously [23] . O 2 -.
production by PLB-985 cells (5ϫ10 5 cells/ml in HBSS) was triggered at 37°C
in the presence of ferricytochrome C (0.4 mg/ml) and the stimulus (10 Ϫ6 M fMLP or 5ϫ10 8 CFU/ml). Absorbance was monitored continuously for 5 min at 550 nm on a Tecan GENios spectrophotometer (Salzburg, Austria), equipped with a thermostated plate holder, and then converted to nmol reduced cytochrome C by using the extinction coefficient of 2.1 ϫ 10 4 M -1 cm -1 .
H 2 O 2 production
Differentiated PLB-985 cells or freshly purified blood neutrophils (10 6 /ml HBSS) were preincubated for 15 min with 1.25 M 2Ј,7Ј-dichlorofluorescein diacetate (DCFH-DA; Sigma-Aldrich Chimie SARL) in a water bath with gentle shaking at 37°C. Cells were then stimulated for 15 min with 50 ng/ml PMA (Sigma-Aldrich Chimie SARL), bacteria (5ϫ10 8 CFU/ml), LPS extracted from the corresponding bacteria (1 g/ml), or inert polystyrene beads (Molecular Probes, Interchim). In some experiments, cells were primed for 20 min with 10 ng/ml IL-8 (R&D Systems, Abingdon, UK) before incubation with bacteria or PMA. H 2 O 2 production was measured with a FACSCalibur as described above.
Cytokine synthesis and signaling analysis
Isolated blood neutrophils or differentiated PLB-985 cells (5ϫ10 6 cells/ml) were cultured for 2 h, 4 h, or 8 h in RPMI-1640 culture medium supplemented with 10% FCS, L-glutamine (2 mmol/ml), and gentamycin (200 g/ml) at 37°C with 5% CO 2 in the presence of the following stimulating agents: 100 g/ml LPS derived from E. coli O55:B5 (Sigma-Aldrich Chimie SARL) plus recombinant human IFN-␥ at 250 IU/ml (R&D Systems), LPS (0.1-1000 ng/ml) isolated from strain AAEC185, IH11128, or C1845, or the different E. coli strains described in Table 1 To better understand the mechanisms of type 1 pili-induced IL-8 synthesis, differentiated PLB-985 (2ϫ10 6 cells/ml) were preincubated for 30 min with 3 M SB203580, 20 M PD98059, or 5 ⌴ PP2 and then stimulated with WT and recombinant strains (5ϫ10 8 CFU/ml) for 5, 15, 30, or 60 min or with 25 ng/ml PMA for 30 min (positive control). Cells were then lysed in lysis buffer as described, and then proteins were resolved by SDS-PAGE and subjected to Western blot analysis.
SDS-PAGE and Western blot analysis
Purified blood neutrophils and PLB-985 cells were resuspended in lysis buffer (10 7 cells/ml) containing 50 mM Tris, 1% Nonidet P-40, 150 mM NaCl, 2 mM EDTA, 1 mM Na 3 VO 4 , 1 mM NaF, 6.25 mM NaPPi, and a cocktail of protease inhibitors (Sigma-Aldrich Chimie SARL) at pH 7.5 for 15 min at 4°C with gentle agitation. Cell lysates were then centrifuged at 13,000 g for 15 min at 4°C to remove insoluble material. The protein concentration was determined with the bicinchoninic acid assay (Pierce, Rockford, IL, USA). Protein (25 g) was denatured by boiling in reducing SDS sample buffer. Proteins were resolved by SDS-PAGE and then transferred to polyvinylidene difluoride (PVDF) membranes (Amersham Pharmacia Biotech, UK). For immunoblotting, membranes were washed with TBS containing 0.1% Tween 20 and blocked in TBS containing 0.1% Tween 20, 3% BSA, and 0.5% gelatin. Membranes were probed overnight with the following specific antibodies: anti-CEACAM1, anti-DAF (R&D Systems), anti-CEACAM6 (Genovac), antiphosphorylated (antip)ERK, anti-pp38 MAPKs, anti-pSrc family kinases (Cell Signaling Technology), anti-ERK, anti-p38, and anti-Src (Cell Signaling Technology). Blots were then incubated with HRP-linked secondary antibodies (Amersham, Orsay, France), followed by chemiluminescence detection with the ECL Plus kit (Perkin Elmer, Les Ulis, France).
Cytokine and MPO assays IL-8, IL-1␤, and TNF-␣ were quantified by using commercial ELISA kits (Quantikine, R&D Systems), as recommended by the manufacturer. The detection limits were 5 pg/ml for IL-8 and TNF-␣ and 1 pg/ml for IL-1␤. MPO was assayed with an ELISA kit from Oxys Bioxytech International Inc. (Portland, OR, USA; detection limit, 0.2 ng/ml).
Statistical analysis
Results are expressed as means Ϯ SEM. Bacteria-and LPS-treated and untreated groups were compared by using ANOVA followed by multiple comparisons of means with Fisher's least significance procedure. The effects of LPS and whole bacteria were compared by using Wilcoxon's paired test. P values of Ͻ0.05 were considered significant.
RESULTS
Differentiated PLB-985 cells constitutively express Afa/Dr DAEC fimbriae receptors, DAF, and CEACAM6 and ␤2 integrin CD11b/CD18, allowing Afa/Dr DAEC adherence PLB-985 myeloid cells [22] were differentiated into terminally mature neutrophils by culture with 0.5% DMF, 1% Nutridoma, and 0.5% FCS, as described by Pedruzzi et al. [23] . The ␤2 integrin expression at the surface of PLB-985 cells differentiated for 6 days was not significantly different from that obtained with PMN freshly isolated from blood, as it was 124 Ϯ 73 and 210 Ϯ 57, respectively, expressed in MFI (meanϮSEM; nϭ3). This reflected the terminal granulocytic maturation of PLB-985 cells, as ␤2 integrin expression increased gradually along the 6-day differentiation period (data not shown).
The expression of receptors for Afa/Dr fimbriae at the PLB-985 cell surface was shown by indirect immunofluorescence, confocal laser-scanning microscopy analysis, flow cytometry, and Western blot analysis. Flow cytometry showed that DAF and CEACAM6 were expressed at the cell surface, as the MFI were, respectively, 86 Ϯ 19 and 15 Ϯ 6 (meanϮSEM; nϭ3). Western blot analysis showed that DAF and CEACAM6 proteins were present at their known molecular masses of 75 kD and 90 kDa, respectively (Fig. 1A) . As shown in Figure 1B , punctuate DAF and CEACAM6 staining was observed at the surface of PLB-985 cells, a pattern characteristic of GPIanchored proteins. However, DAF was concentrated mainly at the cell periphery, whereas CEACAM6 showed a more polar distribution.
In keeping with this DAF and CEACAM6 expression, the recombinant strains expressing Dr and F1845 fimbriae adhered much better to differentiated PLB-985 cells than the control strain. Indeed, 20 Ϯ 6 adhesive AAEC185pDr or 22 Ϯ 5 adhesive AAEC185pF1845 per PLB-985 cell could be counted by fluorescence microscopy, as the number of AAEC185 adhesive bacteria was always lower than three per cell.
Altogether, these results indicate that differentiated PLB-985 cells provide a neutrophil-like model suitable for studying neutrophil functional responses following infectious challenge with Afa/Dr DAEC.
The oxidative burst of differentiated PLB-985 cells is triggered by bacterial recognition
We determine H 2 O 2 and O 2 -. production in response to bacteria. As shown in Figure 2 , differentiated PLB-985 cells produced H 2 O 2 in response to PMA ( Fig. 2A) and to WT IH11128 bacteria (Fig. 2B) . WT IH11128 and WT C1845 bacteria triggered a significant increase in H 2 O 2 production but less efficiently than PMA (Fig. 2C) . Similar results were obtained when using isolated blood neutrophils (data not shown). O 2 -. production increased significantly following challenge with WT IH11128 and C1845 bacteria but less markedly than after challenge with fMLP (Fig. 2D) . IL-8 did not prime the bacteria-induced oxidative burst: Short exposure of PLB-985 cells to IL-8 prior to bacterial stimulation did not increase H 2 O 2 production significantly, whatever the bacterial strain, as IL-8 increased the PMA-induced H 2 O 2 production (data not shown).
We thus examined whether this oxidative burst was Dr or F1845 fimbriae-dependent. For this purpose, the operons encoding Dr and F1845 fimbriae were introduced into the nonpathogenic strain AAEC185. The recombinant strains AAEC185pDr and AAEC185pF1845 also triggered H 2 O 2 production at a level similar to that induced by the two WT strains (Fig. 2C) . Similar results were obtained for O 2 -. production in response to the recombinant E. coli strains (Fig. 2D) . However, the oxidative burst was also triggered by the nonpathogenic strain AAEC185 (Fig. 2, C and D) . The oxidative burst was not triggered by inert polystyrene beads (data not shown). To- (Table 2) . A similar effect was observed following infection of PLB-985 cells with the nonpathogenic strain AAEC185. Thus, like the oxidative burst, the release of IL-8 and MPO preformed stocks from PLB-985 cells in response to E. coli does not appear to be strain-specific.
Late IL-8 production by PLB-985 cells is triggered by Afa/Dr DAEC
Late responses were analyzed in terms of proinflammatory cytokine production. All of the bacterial strains induced similar low levels of IL-1␤ after 8 h of infection (27Ϯ15, 18Ϯ4, and 28Ϯ8 pg/ml/5ϫ10 6 cells with AAEC185, WT IH11128, and WT C1845, respectively), as it was nondetectable in unstimulated control cells. Similar results were obtained for TNF-␣ (122Ϯ14, 50Ϯ3, 76Ϯ10, and 30Ϯ8 pg/ml/5ϫ10 6 cells with AAEC185, WT IH11128, C1845, or control cells, respectively). In the presence of the nonpathogenic AAEC185 control strain and also in basal conditions, differentiated PLB-985 cells released low levels of IL-8 after as little as 4 h of culture, with a small, gradual increase up to 8 h (Fig. 3, A and  B) . Challenge with WT IH11128 or C1845 bacteria increased IL-8 production significantly after 8 h of culture as compared with the control strain AAEC185 (Fig. 3, A-C) . Dr and F1845 fimbriae have been found to increase IL-8 production by cultured human intestinal T84 cells [3] . However, as shown in Figure 3 , A-C, recombinant strains AAEC185pDr and AAEC185pF1845 failed to enhance IL-8 production significantly, as compared with strain AAEC185, indicating that WT IH11128-and C1845-induced IL-8 hyperproduction by PLB-985 cells was independent of Dr and F1845 fimbriae.
Type 1 pili are a major trigger of late IL-8 hyperproduction by PLB-985 cells
We then search to identify the virulence factor(s) present in WT IH11128 and C1845 bacteria, which could be involved potentially in late IL-8 hyperproduction by PLB-985 cells.
As LPS is known to induce IL-8 synthesis [34] , we examined whether LPS, isolated from nonpathogenic E. coli strains AAEC185, WT IH11128, and C1845, could promote late IL-8 production by PLB-985 cells. As shown in Figure 4 , IL-8 production increased in a concentration-dependent manner when PLB-985 cells were treated with LPS-IH11128 and LPS-C1845 but also with LPS from the nonpathogenic strain AAEC185. The levels of IL-8 induced by LPS-IH11128 and LPS-C1845 were ten-to 20-fold lower than those induced by the corresponding whole WT bacteria (Figs. 3 and 4) . Together, these results indicate that WT LPS is not responsible for the late IL-8 hyperproduction by PLB-985 cells following challenge with the WT E. coli strains IH11128 and C1845. Interestingly, LPS from the three strains failed to induce IL-1␤ or TNF-␣ production, regardless of the concentration used (data not shown); it also failed to induce significant release of preformed IL-8 and MPO or to stimulate ROS production (H 2 O 2 and O 2 -.
; Table 3 ). To examine the role of type 1 pili in WT IH11128-and C1845-induced, late IL-8 hyperproduction by PLB-985 cells, we used D-mannose, which is known to inhibit pili 1-dependent host cell recognition [35] and responses [36] . D-mannose led to 50% inhibition of IL-8 release by WT-IH11128-and C1845-infected cells, as compared with untreated, infected cells (Fig. 5A) . The adherent-invasive WT strain LF82 [31] , expressing a type 1 pili variant [32] , also induced significantly higher IL-8 production, which was also inhibited by D-mannose (Fig. 5A) . The recombinant strain AAEC185pSH2, expressing type 1 pili [30] , led to a time-dependent increase in IL-8 production by PLB-985 cells (Figs. 3C and 5B). Moreover, AAEC185pSH2-infected PLB-985 cells produced a significantly higher level of late IL-8 production than AAEC185-infected cells (Fig. 5, B and C) . As expected, the AAEC185pUT2002 mutant strain [30] failed to increase late IL-8 production (Fig. 5C) . Supporting a role of type 1 pili in the induction of late IL-8 production, the recombinant strain AAEC185pAdLF82 expressing the type 1 pili variant of the adherent-invasive WT strain LF82 induced significantly higher, late IL-8 production than the AAEC185 control strain (Fig. 5C ). As expected, D-mannose treatment reduced AAEC185pSH2-and AAEC185pAdLF82-induced IL-8 production significantly (Fig. 5C) . Together, these results demonstrate that the IL-8 hyperproduction by PLB-985 cells after 8 h of challenge by WT Afa/Dr DAEC strains is type 1 pilidependent.
To confirm that PLB-985-differentiated cells are a suitable model, some of these experiments were also done on freshly isolated blood neutrophils. We found that recombinant AAEC185 strains expressing type 1 pili induced significantly higher IL-8 production than the AAEC185 strain, as it was 110 Ϯ 6, 115 Ϯ 11, and 75 Ϯ 3 ng/ml/5 ϫ 10 6 PMN with AAEC185pSH2, AAEC185pAdLF82, and AAEC185, respectively (meanϮSEM of four healthy donors; PϽ0.05).
MAPKs and Src family kinases are involved in type 1 pili-induced, late IL-8 production by PLB-985 cells IL-8 production induced by enterovirulent E. coli is known to be controlled by the MAPK pathway [3, 5, 8] . As shown in Figure  6A , we observed a rapid increase (after 5 min of infection) in pERK and pp38 MAPKs in WT C1845-infected PLB-985 cells. WT C1845-induced pERK was abrogated by the ERK inhibitor PD98059, and pp38 was abrogated by the p38 inhibitor SB203580. In addition, pSrc was observed in WT C1845-infected cells and decreased after treatment with the Src family kinase inhibitor PP2 (Fig. 6A) . A similar increase in pERK and pp38 MAPK was observed with WT strains IH11128 and LF82 and was abrogated by specific inhibitors (Fig. 6B) .
To confirm that type 1 pili trigger strong P-p38 MAPK in PLB-985 cells, we examined the effect of various type 1 pili-expressing, recombinant E. coli strains. As shown in Figure 6C , the recombinant strains AAEC185pSH2 and AAEC185pAdLF82 induced pp38 MAPK, and this effect was prevented by SB203580. As expected, the mutant strain AAEC185pUT2002 induced lower pp38 (Fig. 6C) .
Finally, to demonstrate that type 1 pili-dependent activation of MAPKs and Src kinase controls late IL-8 hyperproduction in this setting, we investigated the effects of specific inhibitors of ERK and p38 MAPKs and of Src family tyrosine kinases on WT C1845-and AAEC185pSH2-mediated IL-8 production by PLB-985 cells after 8 h of challenge (Fig. 7) . The ERK inhibitor PD98059 and the p38 inhibitor SB203580 strongly reduced WT C1845-and AAEC185pSH2-induced late IL-8 production. Genistein, which binds to and inhibits protein tyrosine kinases, and the Src family kinase inhibitor PP2 almost completely inhibited late IL-8 production induced by the two E. coli strains. In conjunction with our other results, these findings strongly suggest that ERK, p38 MAPK, and Src family kinase activation is involved in the IL-8 hyperproduction triggered by type 1 pili-bearing bacteria.
Staurosporine, a PKC inhibitor, and LY294002, a PI-3K inhibitor, had little or no effect (Fig. 7) . Finally, MG-132, an agent that prevents pIB, strongly inhibited WT C1845-and AAEC185pSH2-induced late IL-8 production (Fig. 7) , indicating NF-B pathway activation.
As the AAEC control strain can also induce a low IL-8 production, the effect of inhibitors was investigated in parallel, and similar percentages of inhibition were observed (Fig. 7) . This suggests that type 1 pili activates intracellular pathways also involved in other types of interaction between the AAEC185 strain and the cells.
DISCUSSION
The pathophysiological aim of our study was to examine the neutrophil response to E. coli as a model of what can happen at the intestinal lumen after bacteria-induced transepithelial neutrophil migration. We found that PLB-985 cells, differentiated into fully mature, functional neutrophils, expressed sev- eral receptors involved in the adhesion of E. coli-expressing Afa/Dr fimbriae, including DAF and CEACAM6, both of which are also expressed on human blood neutrophils [37, 38] . PLB-985 cells displayed similar early responses to pathogenic and nonpathogenic E. coli strains, including an oxidative burst and degranulation. Finally, we found that late IL-8 hyperproduction by PLB-985 cells was triggered by type 1 pili and mediated by ERK and p38 MAPK, Src family kinase, and NF-B activation. The first neutrophil response to bacteria is the production of ROS and particularly, O 2 -. and H 2 O 2 in a phenomenon known as the oxidative burst. The neutrophil oxidative burst is dependent on activation of NADPH oxidase (NOX2/gp91phox), a member of the NOX family [17, 18] . The PMN oxidative burst can be "primed" for optimal responsiveness by several proinflammatory cytokines and by LPS [39] . Our observation that pathogenic and nonpathogenic E. coli strains induced an early response is consistent with the enhanced PMN oxidative burst previously reported in response to uropathogenic E. coli (UPEC) [40, 41] .
Differentiated PLB-985 cells contain various types of rapidly mobilizable granules and secretory vesicles. MPO is stored in azurophilic granules and is necessary to transform the O 2 -.
into H 2 O 2 (a more stable ROS) during the oxidative burst [24] . IL-8 is stored in secretory vesicles [42] . We show here that short exposure of PLB-985 cells to pathogenic and nonpathogenic E. coli strains triggers the release of large amounts of preformed MPO and IL-8. This rapid mobilization of preformed IL-8 stores upon E. coli stimulation might play a key role in amplifying local neutrophil recruitment and activation. In turn, the release of MPO, IL-8, and ROS in response to E. coli might be involved in intestinal epithelial damage in certain pathological circumstances.
The second step of our study was then to evaluate the prolonged exposure of PLB-985 cells to the bacteria using cytokine production as a functional marker. Indeed, neutrophils modulate inflammatory processes by producing a wide range of cytokines [20, 24, 42] . We found that after 8 h of challenge with WT E. coli strains IH11128, C1845, or LF82, PLB-985 cells produced small amounts of TNF-␣ and IL-1␤ and large amounts of IL-8.
Experiments with WT, recombinant, and mutant E. coli strains, with and without functional and nonfunctional type 1 pili and a type 1 pili variant, and treatment with Dmannose (a type 1 pili antagonist) showed that type 1 pili were responsible for this strong response and that Dr and F1845 fimbriae were not involved. Similar conclusions could be obtained when using blood neutrophils, confirming that differentiated PLB-985 cells constitute a suitable neutrophil model. Type 1 pili are common, filamentous appendages consisting of several subunits mediating bacterial adhesion and invasion and triggering certain host cell responses [43] . Type 1 pili control the cellular processes necessary for the persistence and recurrence of UTIs, including the formation of intracellular bacterial communities with biofilm-like properties that are protected from host defenses [44] . Receptors for type 1 pili or type 1 pili variants have been detected on intestinal cells (CEACAM6) [45, 46] . As these receptors are also present at the surface of PMN and PLB-985 cells, we can suggest that 8 CFU/ml), WT LF82 (5ϫ10 8 CFU/ml), or WT IH11128 (5ϫ10 8 CFU/ml). (C) PLB-985 cells (5ϫ10 6 cells/ml) were pretreated with 3 M SB203580 for 30 min at 37°C and then stimulated for 30 min with control strain AAEC185 or AAEC185 recombinants bearing AdLF82, pSH2 (type 1 pili), or mutated, nonfunctional type 1 pili (pUT2002). In all of these experiments, cells were then lysed, and protein was loaded on SDS-PAGE and transferred to PVDF membranes. After blocking nonspecific sites, the membranes were probed as indicated with antibodies against pERK, pp38, and pSrc. They were then stripped, washed, and reprobed with antibodies against total forms of ERK, p38, and Src, incubated with HRP-conjugated antibodies, and revealed by adding a chemiluminescent reagent. The figure is representative of five experiments. NS, non-stimulated. CEACAM6 is a good candidate for mediating the type 1 pili-mediated effect reported in our study. The involvement of type 1 pili in the inflammatory response to E. coli is controversial. In a model based on bladder epithelial cells, type 1 pili were found to cooperate with LPS to promote IL-6 production in vitro [47] . However, in a human challenge model with E. coli 83972 fim ϩ , Bergsten et al. [48] recently failed to observe type 1 pili-induced urinary tract inflammation.
We identified the signaling pathways that control type 1 pili-induced, late IL-8 hyperproduction in PLB-985 cells. Rapid P-ERK and P-p38 MAPKs were observed in response to the WT strains C1845 and IH11128. In addition, for the first time, we observed MAPK activation and IL-8 production in response to the Crohn's disease-associated, adherent-invasive WT strain LF82 [31] , expressing a type 1 pili variant [32] . MAPK phosphorylation was also observed when PLB-985 cells were infected with the recombinant strains AAEC185pAdLF82 expressing the type 1 pili variant from LF82 E. coli and the strain AAEC185pSH2 expressing UPEC type 1 pili [30] . In contrast and as expected, a low level of MAPK phosphorylation was observed with strain AAEC185pUT2002, expressing a nonfunctional, mutated type 1 pili [47] . It is interesting to note that Afa/Dr DAEC triggers MAPK activation through different mechanisms in human epithelial intestinal cells and PLB-985 cells. Indeed, in intestinal cells, Betis et al. [3] have reported that IL-8 production involves DAF recognition by Afa/Dr fimbriae, whereas we show here that the PLB-985 cell IL-8 response is type 1 pili-dependent but does not require Afa/Dr fimbriae. In addition, our results suggest that Src family kinase activation is probably required for type 1 pili-induced, late IL-8 hyperproduction by PLB-985 cells. Finally, we provide evidence that this response is also regulated by the NF-B pathway, as pretreatment with a NF-B inhibitor profoundly inhibited WT C1845-and AAEC185pSH2-induced late IL-8 production. When using the AAEC185 control strain as a stimulus, low levels of IL-8 were released through the same activation pathways as type 1 pili-bearing strains. Our results are in keeping with reports showing the role of MAPKs and NF-B for the production of several inflammatory cytokines by stimulated human neutrophils or PLB-985 [42, 49] .
Our findings provide new insights into the proinflammatory response to Afa/Dr DAEC infection. In particular, they reveal a role for type 1 pili expressed by Afa/Dr DAEC, and all other reported cellular responses are Afa/Dr adhesin-dependent [9] . What might be the consequences of Afa/Dr DAEC-induced proinflammatory responses? A recent epidemiological study showed that Afa/Dr DAEC strains inducing IL-8 production by epithelial cells were associated with sporadic diarrhea in children Ͻ5 years of age [13, 50] , confirming the association of Afa/Dr DAEC strains with age-dependent diarrhea [12] . Moreover, cell invasion [50] and flagellae [51] have been implicated in the inflammatory response to clinical isolates expressing Afa/Dr fimbriae or type 1 pili [52] . Experimental studies point to a role of nonpathogenic and pathogenic E. coli in the induction and/or aggravation of IBD [21, 53] , but a role of Afa/Dr DAEC in IBD remains to be demonstrated clinically. Other recent experimental findings suggest that the Afa/Dr DAEC-induced proinflammatory response causes cellular changes compatible with IBD lesions. In a T84 cell model, Afa/Dr DAEC-induced PMN migration promotes TNF-␣ and IL-1␤ hyperproduction and DAF up-regulation [11] , mimicking certain mucosal features in IBD [54] . In a Caco-2 cell model, the interaction between AfaE-III-positive bacteria and DAF results in IFN-␥-dependent up-regulation of MHC class I chain-related gene A molecules, which are strongly expressed at the surface of colonic epithelial cells in patients with IBD and which bind NK cells via NK-G2D receptors [55] . Moreover, in Caco-2 cells forming monolayers, Afa/Dr DAEC infection increases paracellular permeability drastically, leading to the expression of the Sat toxin by Afa/Dr DAEC [56] . This toxin is highly prevalent in IBD-associated E. coli strains belonging to phylogenetic group B2 ϩ D [57] , which also includes Afa/Dr DAEC. Finally, it was reported recently that C1845 could promote vascular endothelial growth factor synthesis by cultured intestinal cells [58] , a cytokine also reported by us to be chemotactic for neutrophils [59] .
Thus, in the course of Afa/Dr DAEC intestinal infection, epithelium-and neutrophil-derived IL-8 could control, at least in part, the flow of neutrophils through the lamina propria. Afa/Dr DAEC-induced IL-8 hyperproduction by PMN might thus be important for inducing and perpetuating local inflammation, and this self-amplifying loop might play a role in the pathogenesis of IBD. Moreover, despite their key beneficial role in bacterial killing, Afa/Dr DAEC-induced ROS generated by PMN could cause structural and functional damage to infected epithelia, thereby disrupting the epithelial barrier. For example, following exposure to ROS, intestinal cells are primed for Fas-mediated cell death, and mucosal permeability and electrolyte transport are enhanced. We are currently attempting to unravel these mechanisms and their possible involvement in IBD.
